Author

W. Almahmeed

h-index 42 View on Semantic Scholar

We have 3 of 370 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Oct 2026

Elevated Lipoprotein(a) in Asian Populations and its Implications for Cardiovascular Disease

Elevated lipoprotein (a) (Lp[a]) is becoming increasingly recognized as a cardiovascular disease risk factor. The relationship of Lp(a) to cardiovascular disease is well characterized in European populations; however, data are lacking in the Asian region. In this scoping review, we aimed to characterize the distributio...

Matthew D'Amore, Wann Jia Loh, David Tak Wai Lui et al. · JACC: Asia · 0 citations

Review Open access Jan 2026

Prodrug Strategies in Atherosclerosis: Targeted Delivery and Therapeutic Advances

Key barriers to clinical translation remain, including poor scalability and reproducibility of nanomaterials, patient variability in plaque biology, limited long‐term safety data, and regulatory challenges for complex nanosystems remain.

Elaheh Mirhadi, W. Almahmeed, Prashant Kesharwani et al. · Cardiovascular Therapeutics · 0 citations

Review Open access Aug 2026

Targeting Overweight and Obesity Phenotypes for Secondary Prevention of Cardiovascular Disease: A Call to Action for the Middle East and Beyond.

About 34 million patients across the Middle East could benefit from secondary prevention of CVD by targeting OAO phenotypes by targeting distinct OAO phenotypes, according to a pooled analysis of registry data and Global Burden of Disease data.

W. Almahmeed, J. Barajas-Gamboa, M. Zubaid et al. · Obesity Reviews · 0 citations